AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3099564
Drug: Cimetidine 1200
RxNorm normalized name: cimetidine 1200 mg-0.9%/500 mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 1200 mg HS (nonrandomized)
Trial: 27646578
Drug: Fish Oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish Oil (FO) alone (1.9 g DHA + EPA/day)
Trial: 27646578
Drug: EGCG alone
RxNorm normalized name: EGCG
DrugBank: Epigallocatechin gallate (DB12116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGCG alone (600 mg/day)
Trial: 27646578
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of FO and EGCG
Trial: 22952184
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation (100 μg Se as l-selenomethionine)
Trial: 20724342
Drug: High-dose telmisartan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose telmisartan (2 mg/kg/d)
Trial: 20724342
Drug: Low-dose telmisartan
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose telmisartan (1 mg/kg/d)
Trial: 11872029
Drug: Digital rectal
RxNorm normalized name: BD Thermometer Digital Rectal (obsolete)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digital rectal examination (DRE) and transrectal ultrasonography (TRUS) as initial screening tests
Trial: 10091520
Drug: Nifedipine-GITS (NIF,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine-GITS (NIF, 30 mg/d)
Trial: 10091520
Drug: Hydrochlorothiazide (HCTZ,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ, 25 mg/d)
Trial: 10091520
Drug: Nifedipine-GITS (NIF,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine-GITS (NIF, 30 mg/d) + Hydrochlorothiazide (HCTZ, 25 mg/d)
Trial: 7751519
Drug: Cetirizine dihydrochloride
RxNorm normalized name: Cetirizine dihydrochloride
DrugBank: Cetirizine (DB00341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cetirizine dihydrochloride 0.25 microgram/ml
Trial: 7751519
Drug: Cetirizine dihydrochloride
RxNorm normalized name: Cetirizine dihydrochloride
DrugBank: Cetirizine (DB00341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cetirizine dihydrochloride 1.0 and 2.5 micrograms/ml
Trial: 7751519
Drug: Cetirizine 10
RxNorm normalized name: cetirizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 10 and 20 mg/day
Trial: 1979241
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg cetirizine b.i.d.
Trial: 1979241
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg terfenadine b.i.d. (Control)
Trial: 23695900
Drug: Phonomotor treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phonomotor treatment (60 hours over 6 weeks)
Trial: 15678052
Drug: Antiarrhythmic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic therapy for 1 week (group A)
Trial: 15678052
Drug: Antiarrhythmic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic therapy for 3 weeks (group B)
Trial: 15678052
Drug: Antiarrhythmic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic therapy for 6 weeks (group C)
Trial: 12707430
Drug: Venlafaxine 225
RxNorm normalized name: venlafaxine 225 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine 225 mg
Trial: 8916821
Drug: High-dose tranexamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose tranexamic acid (maximum of 20 g)
Trial: 1670840
Drug: calcipotriol ointment
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: calcipotriol ointment 50 micrograms/g
Trial: 1670840
Drug: betamethasone valerate
RxNorm normalized name: Betamethasone Valerate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: betamethasone valerate ointment 0.1%
Trial: 30924154
Drug: DSP-0565 administered
RxNorm normalized name: tolnaftate
DrugBank: Tolnaftate (DB00525)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DSP-0565 administered orally to rats and dogs
Trial: 29916979
Drug: Deliberate practice
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deliberate practice combined with speech therapy based on the Whole Language Model
Trial: 29916979
Drug: Speech therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Speech therapy based on the Whole Language Model (Control)
Trial: 26663215
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy using methyl aminolaevulinate (MAL, 80 mg g(-1))
Trial: 22320349
Drug: Exenatide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide (10 µg subcutaneous injection)
Trial: 17414741
Drug: Milnacipran 25
RxNorm normalized name: milnacipran 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milnacipran 25 mg twice daily, then 50 mg twice daily until the 10th week
Trial: 16263999
Drug: Heliox (70%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heliox (70% helium, 30% oxygen) driven nebulized albuterol (15 mg/hour)
Trial: 16263999
Drug: Oxygen (100%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen (100% oxygen) driven nebulized albuterol (15 mg/hour)
Trial: 12537614
Drug: Voice therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voice therapy intervention
Trial: 9699783
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids (early use)
Trial: 9699783
Drug: Different drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different drugs or different doses of drug
Trial: 8729740
Drug: Glycerin (GL)
RxNorm normalized name: Glycerin
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycerin (GL) placebo patches
Trial: 2172349
Drug: Nedocromil sodium,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium, 1% nasal solution, one spray per nostril, four times daily for 8 weeks
Trial: 2172349
Drug: Cromolyn sodium,
RxNorm normalized name: Cromolyn Sodium, compounding powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cromolyn sodium, 4% nasal solution, one spray per nostril, four times daily for 8 weeks
Trial: 2172349
Drug: Placebo, one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, one spray per nostril, four times daily for 8 weeks
Trial: 21639923
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicine (specific formula not detailed)
Trial: 8844923
Drug: Maternal behavioral
RxNorm normalized name: undecylenate
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maternal behavioral and psychosocial factors (e.g., smoking, low weight for height, negative mood, rejection of pregnancy)
Trial: 1727997
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of Curosurf (200 mg/kg)
Trial: 1727997
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of Curosurf (200 mg/kg initial dose + 2 additional doses of 100 mg/kg each)
Trial: 6091478
Drug: Ceftriaxone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (1 g every 12 hours)
Trial: 6091478
Drug: Gentamicin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin (1 mg/kg every 8 hours) plus Clindamycin (8 mg/kg every 6 hours)
Trial: 20851080
Drug: LEISH-F1+MPL-SE vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LEISH-F1+MPL-SE vaccine (5, 10, or 20 μg recombinant Leishmania polyprotein LEISH-F1 antigen + 25 μg MPL(®)-SE adjuvant)
Trial: 17611080
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of psychological treatment and anti-psychotic medication
Trial: 16372586
Drug: Telmisartan titrated
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan titrated to 40 mg
Trial: 16372586
Drug: Telmisartan titrated
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan titrated to 80 mg
Trial: 12789723
Drug: AK‐2123 (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AK‐2123 (600 mg/m2 on alternate days)
Trial: 12789723
Drug: Control (external
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (external radiation with telecobalt to a dose of 50 Gy and intracavitary radiation of 20 Gy)
Trial: 11518092
Drug: Methylphenidate (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (10 mg dose)
Trial: 11518092
Drug: Methylphenidate (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (higher doses)
Trial: 7962318
Drug: 12.5 mg
RxNorm normalized name: rutin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg hydrocortisone hemisuccinate
Trial: 7962318
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg hydrocortisone hemisuccinate
Trial: 7962318
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg hydrocortisone hemisuccinate
Trial: 12791621
Drug: Chewing gum
RxNorm normalized name: Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewing gum containing 1 mg nicotine and 0 mg caffeine
Trial: 12791621
Drug: Chewing gum
RxNorm normalized name: Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewing gum containing 2 mg nicotine and 0 mg caffeine
Trial: 12791621
Drug: Chewing gum
RxNorm normalized name: Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewing gum containing 1 mg nicotine and 50 mg caffeine
Trial: 12791621
Drug: Chewing gum
RxNorm normalized name: Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewing gum containing 2 mg nicotine and 50 mg caffeine
Trial: 12791621
Drug: Chewing gum
RxNorm normalized name: Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewing gum containing 1 mg nicotine and 100 mg caffeine
Trial: 12791621
Drug: Chewing gum
RxNorm normalized name: Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewing gum containing 2 mg nicotine and 100 mg caffeine
Trial: 12791621
Drug: Placebo (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0 mg nicotine and 0 mg caffeine)
Trial: 1338387
Drug: Fluoxetine, 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine, 60 mg daily for 14 days
Trial: 24148020
Drug: Immediate loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate loading of implants with a converted pre-existing denture on the day of surgery.
Trial: 24148020
Drug: Delayed loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed loading of implants (control group) with soft-relined pre-existing denture.
Trial: 17621644
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg daily (titrated to a maximum of 120 mg daily)
Trial: 12560163
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro Mix25
Trial: 10767227
Drug: Outpatient rehabilitation
RxNorm normalized name: GLUTATHIONE 12.5 g in 100 mL ORAL LIQUID [K2LTS Brain Rehabilitation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient rehabilitation program including 3 months of breathing retraining and chest physiotherapy, 3 months of daily supervised exercise, and 6 months of weekly supervised breathing exercises
Trial: 21751299
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment acceptance
Trial: 19189603
Drug: Bromocriptine (BRC)
DrugBank: Bromocriptine (DB01200)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bromocriptine (BRC) 1.25‐8.75 mg per day
Trial: 16291415
Drug: Topiramate (25-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (25-600 mg/d for 26 weeks)
Trial: 7572704
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g ethanol
Trial: 1938771
Drug: Metaproterenol sulfate
RxNorm normalized name: Metaproterenol Sulfate
DrugBank: Orciprenaline (DB00816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metaproterenol sulfate (Alupent) metered dose inhaler
Trial: 7006708
Drug: Bone marrow
RxNorm normalized name: bone marrow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone marrow transplantation with cyclophosphamide (CY) 60 mg/kg/day for 2 days, 1000 rad total body irradiation, and a marrow transplant from a genotypically identical normal twin.
Trial: 7006708
Drug: Immunotherapy consisting
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy consisting of killed autologous leukemic cells and/or normal twin peripheral blood lymphocytes.
Trial: 7006708
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not specified, but includes patients who did not receive additional chemotherapy before CY).
Trial: 25802961
Drug: Low-intensity wheelchair
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-intensity wheelchair training (30%–40% heart rate reserve, twice a week, 30 mins per session for 16 weeks)
Trial: 21434339
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment in Group F
Trial: 3887394
Drug: Prophylactic anti-lymphocyte
RxNorm normalized name: lymphocyte immune globulin, anti-thymocyte globulin
DrugBank: Antilymphocyte immunoglobulin (horse) (DB09312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic anti-lymphocyte globulin (ALG) combined with azathioprine and steroids for 8.7 +/- 2.25 days after transplantation, followed by cyclosporine and steroids.
Trial: 3887394
Drug: Azathioprine and
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine and steroids only (control group).
Trial: 29338113
Drug: sacubitril/valsartan 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sacubitril/valsartan 200 mg (97/103 mg)
Trial: 24341948
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg metronidazole tablet (Flagyl®)
Trial: 24341948
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g of 15% metronidazole benzoate gel
Trial: 19913119
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (single infusion)
Trial: 19913119
Drug: Placebo (sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (sodium chloride infusion)
Trial: 10492054
Drug: Controlled-release oxycodone
RxNorm normalized name: oxycodone
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Controlled-release oxycodone 40 mg
Trial: 10492054
Drug: Controlled-release morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release morphine 45 mg
Trial: 10492054
Drug: Controlled-release morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release morphine 90 mg
Trial: 8564100
Drug: Inhaled PGE2
RxNorm normalized name: PGE2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Inhaled PGE2 (100 micrograms in 4 ml saline)
Trial: 6988176
Drug: 0.25% desoxymethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% desoxymethasone in an oily cream base
Trial: 6988176
Drug: 0.1% hydrocortisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% hydrocortisone 17-butyrate cream
Trial: 6988176
Drug: Oily cream
RxNorm normalized name: OILY CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oily cream base alone
Trial: 28732523
Drug: Collabri model
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collabri model for collaborative care (CC)
Trial: 19230029
Drug: Intravenous glutathione
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous glutathione 1,400 mg administered three times a week for 4 weeks
Trial: 19230029
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered three times a week for 4 weeks
Trial: 19230029
Drug: Intravenous glutathione
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous glutathione 1,400 mg
Trial: 15358690
Drug: bosentan (62.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bosentan (62.5 mg b.i.d for 4 weeks then 125 mg b.i.d)
Trial: 7525192
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination antihypertensive therapy
Trial: 7525192
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination therapy
Trial: 7525192
Drug: Thiazide diuretic
RxNorm normalized name: Thiazide diuretic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiazide diuretic with potassium-sparing diuretic, β-blocker, or ACE inhibitor
Trial: 7525192
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blocker with β-blocker or ACE inhibitor
Trial: 627044
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg tartrazine
Trial: 21197536
Drug: Levosimendan in
RxNorm normalized name: levosimendan Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosimendan in addition to conventional heart failure therapy
Trial: 21197536
Drug: Conventional heart
RxNorm normalized name: porcine heart preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional heart failure therapy (control group)
Trial: 21197536
Drug: Levosimendan in
RxNorm normalized name: levosimendan Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosimendan in addition to conventional therapy
Trial: 19491859
Drug: Balsalazide 3.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balsalazide 3.3 g (1.1 g tablet, twice daily for 8 weeks)
Trial: 16157113
Drug: High-dose vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vaginal misoprostol (600 microg x 1, then 400 microg every 4 hours x 5)
Trial: 16157113
Drug: Concentrated intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concentrated intravenous oxytocin plus low-dose vaginal misoprostol (oxytocin 277-1667 mU/min plus 400 microg x 1, then 200 microg every 6 hours x 2, then 100 microg x 1)
Trial: 16157113
Drug: High-dose vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vaginal misoprostol
Trial: 16157113
Drug: Concentrated intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concentrated intravenous oxytocin plus low-dose vaginal misoprostol
Trial: 2118322
Drug: Cefixime 400
RxNorm normalized name: cefixime 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 400 mg daily, orally
Trial: 2118322
Drug: Cephalexin 250
RxNorm normalized name: cephalexin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephalexin 250 mg four times a day, orally
Trial: 6112447
Drug: UK‐37 248
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UK‐37 248 (200 mg)
Trial: 23078148
Drug: Fluticasone/formoterol (100/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone/formoterol (100/10 μg b.i.d.)
Trial: 7555622
Drug: Carbamazepine (CBZ),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbamazepine (CBZ), titrated to 4-12 micrograms/ml
Trial: 2208421
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of Scutellaria compound
Trial: 2208421
Drug: Intravenous piperacillin
RxNorm normalized name: Piperacillin
DrugBank: Piperacillin (DB00319)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous piperacillin sodium
Trial: 24517055
Drug: TCM treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCM treatment group (combined A and B)
Trial: 21639808
Drug: dacarbazine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dacarbazine (1000 mg/m² intravenously every 3 weeks)
Trial: 19853906
Drug: Liraglutide 2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide 2.4 mg
Trial: 19853906
Drug: Liraglutide 1.8-3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide 1.8-3.0 mg
Trial: 10965733
Drug: Propofol 1%
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol 1% (10 mg/ml)
Trial: 10965733
Drug: Propofol 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2% (20 mg/ml)
Trial: 8911979
Drug: Glimepiride at
RxNorm normalized name: Glimepiride
DrugBank: Glimepiride (DB00222)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glimepiride at a daily dose of 1-6 mg for 3 months in NIDDM patients with kidney disease
Trial: 6509875
Drug: 0.9% sodium
RxNorm normalized name: LMD with 0.9% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% sodium chloride injection alone